Docking and DFT Studies to explore the Topoisomerase II ATP Pocket employing 3-Substituted 2,6-Piperazindiones for drug design

Author： Correa-Basurto J.   Ramos-Morales F. R.   Matus M. H.   Rosales-Hernández M. C.   Mancilla-Percino T.   Trujillo-Ferrara J.   Ilizaliturri-Flores I.  

Publisher： Taylor & Francis Ltd

ISSN： 0892-7022

Source： Molecular Simulation, Vol.38, Iss.13, 2012-11, pp. : 1072-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Drug Design: Docking and Scoring

By  

Current Protein and Peptide Science, Vol. 8, Iss. 4, 2007-08 ,pp. : 312-328

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease

By  

Protein and Peptide Letters, Vol. 21, Iss. 8, 2014-06 ,pp. : 815-827

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of drug sensitivity in yeast cells by the ATP‐binding domain of human DNA topoisomerase IIα

By Vilain Nathalie   Tsai‐Pflugfelder Monika  

Nucleic Acids Research, Vol. 31, Iss. 19, 2003-10 ,pp. : 5714-5722

Oxford University Press

Access to resources Recommend Favorite

mAMSA resistant human topoisomerase II mutation G465D has reduced ATP hydrolysis activity

By Gilroy Kathryn L.   Leontiou Chrysoula   Padget Kay   Lakey Jeremy H.   Austin Caroline A.  

Nucleic Acids Research, Vol. 34, Iss. 5, 2006-01 ,pp. : 1597-1607

Oxford University Press

Access to resources Recommend Favorite

Binding mode analysis of dual inhibitors of human thymidylate synthase and dihydrofolate reductase as antitumour agents via molecular docking and DFT studies

By Arooj Mahreen   Lee Keun Woo  

Molecular Simulation, Vol. 41, Iss. 4, 2015-03 ,pp. : 311-314

Taylor & Francis Ltd

Access to resources Recommend Favorite